Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 23258614)

1.

Ephrin-A1 mRNA is associated with poor prognosis of colorectal cancer.

Yamamoto H, Tei M, Uemura M, Takemasa I, Uemura Y, Murata K, Fukunaga M, Ohue M, Ohnishi T, Ikeda K, Kato T, Okamura S, Ikenaga M, Haraguchi N, Nishimura J, Mizushima T, Mimori K, Doki Y, Mori M.

Int J Oncol. 2013 Feb;42(2):549-55. doi: 10.3892/ijo.2012.1750. Epub 2012 Dec 21.

PMID:
23258614
2.

Association between ephrin-A1 mRNA expression and poor prognosis after hepatectomy to treat hepatocellular carcinoma.

Wada H, Yamamoto H, Kim C, Uemura M, Akita H, Tomimaru Y, Hama N, Kawamoto K, Kobayashi S, Eguchi H, Umeshita K, Doki Y, Mori M, Nagano H.

Int J Oncol. 2014 Sep;45(3):1051-8. doi: 10.3892/ijo.2014.2519. Epub 2014 Jun 24.

PMID:
24969670
3.

Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.

Uen YH, Lin SR, Wu DC, Su YC, Wu JY, Cheng TL, Chi CW, Wang JY.

Ann Surg. 2007 Dec;246(6):1040-6.

PMID:
18043108
4.

Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer.

Ide T, Kitajima Y, Ohtaka K, Mitsuno M, Nakafusa Y, Miyazaki K.

Oncol Rep. 2008 Jun;19(6):1571-6.

PMID:
18497967
5.

Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.

Xue G, Hao LQ, Ding FX, Mei Q, Huang JJ, Fu CG, Yan HL, Sun SH.

J Clin Gastroenterol. 2009 Oct;43(9):831-7. doi: 10.1097/MCG.0b013e31819cc731.

PMID:
19461527
6.

Prognostic role of p53 messenger ribonucleic acid expression in patients after curative resection for stage I to III colorectal cancer: association with colon cancer stem cell markers.

Huh JW, Kim HR, Kim YJ.

J Am Coll Surg. 2013 Jun;216(6):1063-9. doi: 10.1016/j.jamcollsurg.2013.01.058. Epub 2013 Apr 6.

PMID:
23571142
7.

CXCL10 expression and prognostic significance in stage II and III colorectal cancer.

Jiang Z, Xu Y, Cai S.

Mol Biol Rep. 2010 Jul;37(6):3029-36. doi: 10.1007/s11033-009-9873-z. Epub 2009 Oct 10.

PMID:
19821051
8.

Clinical significance of UNC5B expression in colorectal cancer.

Okazaki S, Ishikawa T, Iida S, Ishiguro M, Kobayashi H, Higuchi T, Enomoto M, Mogushi K, Mizushima H, Tanaka H, Uetake H, Sugihara K.

Int J Oncol. 2012 Jan;40(1):209-16. doi: 10.3892/ijo.2011.1201. Epub 2011 Sep 15.

PMID:
21922135
9.

Clinical significance of BMP7 in human colorectal cancer.

Motoyama K, Tanaka F, Kosaka Y, Mimori K, Uetake H, Inoue H, Sugihara K, Mori M.

Ann Surg Oncol. 2008 May;15(5):1530-7. doi: 10.1245/s10434-007-9746-4. Epub 2008 Feb 8.

PMID:
18259822
10.

rs12904 polymorphism in the 3'UTR of EFNA1 is associated with colorectal cancer susceptibility in a Chinese population.

Mao YY, Jing FY, Jin MJ, Li YJ, Ding Y, Guo J, Wang FJ, Jiang LF, Chen K.

Asian Pac J Cancer Prev. 2013;14(9):5037-41.

11.

Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.

Iinuma H, Watanabe T, Mimori K, Adachi M, Hayashi N, Tamura J, Matsuda K, Fukushima R, Okinaga K, Sasako M, Mori M.

J Clin Oncol. 2011 Apr 20;29(12):1547-55. doi: 10.1200/JCO.2010.30.5151. Epub 2011 Mar 21.

12.

Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer.

Jiang Z, Wang Z, Xu Y, Wang B, Huang W, Cai S.

Biosci Rep. 2010 Dec;30(6):383-90. doi: 10.1042/BSR20090129.

13.

High TrkB expression levels are associated with poor prognosis and EMT induction in colorectal cancer cells.

Fujikawa H, Tanaka K, Toiyama Y, Saigusa S, Inoue Y, Uchida K, Kusunoki M.

J Gastroenterol. 2012 Jul;47(7):775-84. doi: 10.1007/s00535-012-0532-0. Epub 2012 Feb 24.

PMID:
22361863
14.

Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.

Yokobori T, Iinuma H, Shimamura T, Imoto S, Sugimachi K, Ishii H, Iwatsuki M, Ota D, Ohkuma M, Iwaya T, Nishida N, Kogo R, Sudo T, Tanaka F, Shibata K, Toh H, Sato T, Barnard GF, Fukagawa T, Yamamoto S, Nakanishi H, Sasaki S, Miyano S, Watanabe T, Kuwano H, Mimori K, Pantel K, Mori M.

Cancer Res. 2013 Apr 1;73(7):2059-69. doi: 10.1158/0008-5472.CAN-12-0326. Epub 2013 Feb 1.

15.

Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.

Kahlert C, Lahes S, Radhakrishnan P, Dutta S, Mogler C, Herpel E, Brand K, Steinert G, Schneider M, Mollenhauer M, Reissfelder C, Klupp F, Fritzmann J, Wunder C, Benner A, Kloor M, Huth C, Contin P, Ulrich A, Koch M, Weitz J.

Clin Cancer Res. 2011 Dec 15;17(24):7654-63. doi: 10.1158/1078-0432.CCR-10-2816. Epub 2011 Oct 31.

16.

Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.

Wang X, Wang J, Ma H, Zhang J, Zhou X.

Med Oncol. 2012 Jun;29(2):919-27. doi: 10.1007/s12032-011-9880-5. Epub 2011 Mar 10.

PMID:
21390519
17.

Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis.

Shi H, Zhou Y, Liu H, Chen C, Li S, Li N, Li X, Zhang X, Zhang H, Wang W, Zhao Q.

BMC Cancer. 2010 Sep 3;10:477. doi: 10.1186/1471-2407-10-477.

18.
19.

A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.

Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W.

Gastroenterology. 2009 Jul;137(1):165-75. doi: 10.1053/j.gastro.2009.03.041. Epub 2009 Mar 26.

PMID:
19328798
20.

MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.

Christensen LL, Tobiasen H, Holm A, Schepeler T, Ostenfeld MS, Thorsen K, Rasmussen MH, Birkenkamp-Demtroeder K, Sieber OM, Gibbs P, Lubinski J, Lamy P; COLOFOL steering group, Laurberg S, Oster B, Hansen KQ, Hagemann-Madsen R, Byskov K, ├śrntoft TF, Andersen CL.

Int J Cancer. 2013 Jul;133(1):67-78. doi: 10.1002/ijc.28010. Epub 2013 Feb 12.

PMID:
23280316
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk